Published in Expert Opin Pharmacother on November 01, 2010
Antemortem pulse pressure elevation predicts cerebrovascular disease in autopsy-confirmed Alzheimer's disease. J Alzheimers Dis (2012) 0.95
Genetic variation in CYP17A1 is associated with arterial stiffness in diabetic subjects. Exp Diabetes Res (2012) 0.82
Arterial stiffness and stroke: de-stiffening strategy, a therapeutic target for stroke. Stroke Vasc Neurol (2017) 0.75
Management of familial heterozygous hypercholesterolemia: Position Paper of the Polish Lipid Expert Forum. J Clin Lipidol (2013) 1.58
Does sodium intake affect the relationship between blood pressure and vascular damage? Pol Arch Med Wewn (2015) 1.40
Increased prevalence of cardiovascular risk factors in patients with acute coronary syndrome and indications for treatment with oral anticoagulation. Kardiol Pol (2011) 1.40
Towards Participatory Geographic Information Systems for community-based environmental decision making. J Environ Manage (2008) 1.35
Arterial stiffness, pulse pressure, and cardiovascular disease-is it possible to break the vicious circle? Atherosclerosis (2011) 1.15
Arterial stiffness, central hemodynamics, and cardiovascular risk in hypertension. Vasc Health Risk Manag (2011) 1.02
Central blood pressure and hypertension: role in cardiovascular risk assessment. Clin Sci (Lond) (2009) 0.97
Depression, anxiety, and risk factor control in patients after hospitalization for coronary heart disease: the EUROASPIRE III Study. Eur J Prev Cardiol (2012) 0.90
Benefits of the RAS blockade: clinical evidence before the ONTARGET study. J Hypertens Suppl (2009) 0.90
Potential energy surface for interactions between two hydrogen molecules. J Chem Phys (2008) 0.87
What do Polish interventional cardiologists know about indications and qualification for recanalisation of chronic total coronary artery occlusions? Kardiol Pol (2015) 0.87
Recanalisation of coronary chronic total occlusion by retrograde approach: the first experience in Poland. Kardiol Pol (2014) 0.85
Pulmonary artery pulse wave velocity in idiopathic pulmonary arterial hypertension. Can J Cardiol (2012) 0.82
Second virial coefficients of H2 and its isotopologues from a six-dimensional potential. J Chem Phys (2012) 0.81
Lipid-lowering drugs and homocysteine. A comparison between statins and other lipid-lowering drugs. Atherosclerosis (2004) 0.79
Intraaortic pulse pressure amplification in subjects at high coronary risk. Hypertension (2010) 0.78
Clinical implications of non-invasive measurement of central aortic blood pressure. Curr Vasc Pharmacol (2010) 0.78
Cost-effectiveness of a cardiovascular disease primary prevention programme in a primary health care setting. Results of the Polish part of the EUROACTION project. Kardiol Pol (2013) 0.77
Polish forum for prevention guidelines on smoking. Kardiol Pol (2008) 0.76
Determinants of appropriate lipid management in patients with ischaemic heart disease. Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. Int J Cardiol (2003) 0.76
Ezetimibe: New perspectives in lipid lowering treatment. Cardiol J (2007) 0.76
Factors related to the effectiveness of hypercholesterolemia treatment following hospitalization for coronary artery disease. Pol Arch Med Wewn (2016) 0.75
Relationship between reduced elasticity of extracardiac vessels and left main stem coronary artery disease. Eur Heart J (2005) 0.75
Central blood pressure and cardiovascular risk. J Hypertens (2009) 0.75
[Actual problems of dyslipidaemia treatment in Poland - 2nd Declaration of Sopot. Experts' Group Consensus endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy]. Kardiol Pol (2014) 0.75
Relation between ascending aortic pressures and outcomes in patients with angiographically demonstrated coronary artery disease. Am J Cardiol (2006) 0.75
[Management of familial heterozygous hypercholesterolaemia. Position paper of the Polish Lipid Expert Forum]. Kardiol Pol (2013) 0.75
Letter by Safar and Jankowski regarding article, "Arterial stiffness and cardiovascular events: the Framingham Heart Study". Circulation (2010) 0.75
Letter by Jankowski regarding article, "Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress". Circulation (2006) 0.75
INTERHEART. Lancet (2005) 0.75
Pulse pressure and restenosis after percutaneous coronary angioplasty. Am J Cardiol (2002) 0.75
Polish Forum for Prevention Guidelines on Prophylactic Pharmacotherapy: update 2017. Kardiol Pol (2017) 0.75
[Comprehensive treatment of nicotine dependence in patients with cardiovascular diseases--personal experience]. Psychiatr Pol (2004) 0.75
[Cracovian program for secondary prevention of ischemic heart disease. Methods of intervention]. Przegl Lek (2003) 0.75
Polish Forum for Prevention Guidelines on Diabetes: update 2017. Kardiol Pol (2017) 0.75
Public spirometry campaign in chronic obstructive pulmonary disease screening - hope or hype? Adv Respir Med (2017) 0.75
OS 13-09 RELATIONSHIP BETWEEN 24 HOUR AMBULATORY CENTRAL BLOOD PRESSURE AND LEFT VENTRICULAR MASS - A PROSPECTIVE MULTICENTER STUDY. J Hypertens (2016) 0.75
[Secondary prevention of ischemic heart disease in diabetics in clinical practice]. Pol Arch Med Wewn (2004) 0.75
Polish Forum for Prevention Guidelines on Cardiovascular Risk Assessment: update 2016. Kardiol Pol (2017) 0.75
Asymmetric pulmonary oedema. Int J Cardiol (2005) 0.75
Subtleties in asymmetric catalyst structure: the resolution of a 6-phospha-2,4,8-trioxa-adamantane and its applications in asymmetric hydrogenation catalysis. Chem Commun (Camb) (2009) 0.75
[Acute myocardial infarction complicated by cardiogenic shock treated with angioplasty of left main stenosis - two case reports]. Kardiol Pol (2002) 0.75
Acute pulmonary embolism mimicking STEMI. Do the potential benefits of pulmonary artery angiography support the decision to perform the procedure? Przegl Lek (2014) 0.75
Relationship between past myocardial infarction, periodontal disease and Porphyromonas gingivalis serum antibodies: A case-control study. Cardiol J (2017) 0.75
Management of familial heterozygous hypercholesterolemia. Position paper of the Polish Lipid Expert Forum. Pol Arch Med Wewn (2013) 0.75
Polish Forum for Prevention of Cardiovascular Diseases Guidelines on prophylactic pharmacotherapy. Kardiol Pol (2011) 0.75
[Intracoronary thrombolysis combined with platelet receptor IIb/IIIa inhibitor and followed by percutaneous coronary intervention for the treatment of acute myocardial infarction: two case reports]. Kardiol Pol (2004) 0.75
Association between central and peripheral blood pressure and periodontal disease in patients with a history of myocardial infarction. Pol Arch Med Wewn (2016) 0.75
[Severe hypercholesterolaemia - when to use the proprotein convertase subtilisin-kexin type 9 protease inhibitors (PCSK9 inhibitors)? Polish Society of Cardiology experts' group statement]. Kardiol Pol (2016) 0.75
[Recurrent cardiac arrest due to electro-mechanical dissociation in a patient with variant angina -- a case report]. Kardiol Pol (2006) 0.75
Polish Forum for Prevention Guidelines on Hypertension: update 2017. Kardiol Pol (2017) 0.75
[Percutaneous coronary angioplasty in acute myocardial infarction in elderly patients]. Kardiol Pol (2004) 0.75
Intracoronary ultrasound-guided angioplasty for coronary chronic total occlusion. Kardiol Pol (2009) 0.75
[Primary percutaneous coronary interventions in acute myocardial infraction with ST-segment elevation. Experience in a heart catheterization unit without surgical backup]. Przegl Lek (2004) 0.75
OS 13-09 RELATIONSHIP BETWEEN 24 HOUR AMBULATORY CENTRAL BLOOD PRESSURE AND LEFT VENTRICULAR MASS - A PROSPECTIVE MULTICENTER STUDY. J Hypertens (2016) 0.75
Polish Forum for Prevention Guidelines on Smoking: update 2017. Kardiol Pol (2017) 0.75
Management of obesity in the times of climate change and COVID-19: an interdisciplinary expert consensus report. Pol Arch Intern Med (2022) 0.75
[The influence of percutaneous coronary recanalization of total coronary occlusions on the heart rate variability ]. Przegl Lek (2002) 0.75
Polish Forum for Prevention Guidelines for screening procedures for cardiovascular diseases. Kardiol Pol (2011) 0.75
[Cracovian program for secondary prevention of ischemic heart disease. Secondary prevention of ischemic heart disease during hospitalization in 1996-97 and 1998-99]. Przegl Lek (2003) 0.75
[Pheochromocytoma mimicking acute myocarditis]. Kardiol Pol (2004) 0.75
The challenge of blood pressure control in patients with ischaemic heart disease in Europe. Blood Press Suppl (2005) 0.75
Polish Forum for Prevention Guidelines on Dyslipidaemia: update 2016. Kardiol Pol (2017) 0.75
[Biological treatment of inflammatory bowel diseases in children in the years 2004-2013 in Poland]. Pol Merkur Lekarski (2014) 0.75
[Statement on the diagnosis and treatment of tobacco dependence in patients with cardiovascular diseases]. Kardiol Pol (2011) 0.75